Time filter

Source Type

Utrecht, Netherlands

Utrecht University is a university in Utrecht, the Netherlands. It is one of the oldest universities in the Netherlands and one of the largest in Europe. Established March 26, 1636, it had an enrollment of 30,449 students in 2012, and employed 5,295 faculty and staff. In 2011, 485 PhD degrees were awarded and 7,773 scientific articles were published. The 2013 budget of the university was €765 million.The university is rated as the best university in the Netherlands by the Shanghai Ranking of World Universities 2013, and ranked as the 13th best European university and the 52nd best university of the world.The university's motto is "Sol Iustitiae Illustra Nos," which means "Sun of Justice, shine upon us." This motto was gleaned from a literal Latin Bible translation of Malachi 4:2. Utrecht University is led by the University Board, consisting of prof. dr. Bert van der Zwaan and Hans Amman. Wikipedia.

The objective of this study was to examine the association of the intensity of treatment, ranging from high-dose intensive factor VIII (FVIII) treatment to prophylactic treatment, with the inhibitor incidence among previously untreated patients with severe hemophilia A. This cohort study aimed to include consecutive patients with a FVIII activity < 0.01 IU/mL, born between 2000 and 2010, and observed during their first 75 FVIII exposure days. Intensive FVIII treatment of hemorrhages or surgery at the start of treatment was associated with an increased inhibitor risk (adjusted hazard ratio [aHR], 2.0; 95% confidence interval [CI], 1.3-3.0). High-dose FVIII treatment was associated with a higher inhibitor risk than low-dose FVIII treatment (aHR, 2.3; 95% CI, 1.0-4.8). Prophylaxis was only associated with a decreased overall inhibitor incidence after 20 exposure days of FVIII. The association with prophylaxis was more pronounced in patients with low-risk F8 genotypes than in patients with high-risk F8 genotypes (aHR, 0.61, 95% CI, 0.19-2.0 and aHR, 0.85, 95% CI, 0.51-1.4, respectively). In conclusion, our findings suggest that in previously untreated patients with severe hemophilia A, high-dosed intensive FVIII treatment increases inhibitor risk and prophylactic FVIII treatment decreases inhibitor risk, especially in patients with low-risk F8 mutations. Source

Donega C.D.M.,University Utrecht
Chemical Society Reviews | Year: 2011

Colloidal heteronanocrystals (HNCs) can be regarded as solution-grown inorganic-organic hybrid nanomaterials, since they consist of inorganic nanoparticles that are coated with a layer of organic ligand molecules. The hybrid nature of these nanostructures provides great flexibility in engineering their physical and chemical properties. The inorganic particles are heterostructured, i.e. they comprise two (or more) different materials joined together, what gives them remarkable and unique properties that can be controlled by the composition, size and shape of each component of the HNC. The interaction between the inorganic component and the organic ligand molecules allows the size and shape of the HNCs to be controlled and gives rise to novel properties. Moreover, the organic surfactant layer opens up the possibility of surface chemistry manipulation, making it possible to tailor a number of properties. These features have turned colloidal HNCs into promising materials for a number of applications, spurring a growing interest on the investigation of their preparation and properties. This critical review provides an overview of recent developments in this rapidly expanding field, with emphasis on semiconductor HNCs (e.g., quantum dots and quantum rods). In addition to defining the state of the art and highlighting the key issues in the field, this review addresses the fundamental physical and chemical principles needed to understand the properties and preparation of colloidal HNCs (283 references). © 2011 The Royal Society of Chemistry. Source

Clevers H.,University Utrecht
Nature Medicine | Year: 2011

Over the last decade, the notion that tumors are maintained by their own stem cells, the so-called cancer stem cells, has created great excitement in the research community. This review attempts to summarize the underlying concepts of this notion, to distinguish hard facts from beliefs and to define the future challenges of the field. © 2011 Nature America, Inc. All rights reserved. Source

Adan R.A.H.,University Utrecht
Trends in Neurosciences | Year: 2013

Regulation of body weight is organized by distributed brain circuits that use a variety of neuropeptides and transmitters, and that are responsive to endocrine and metabolic signals. Targeting of these circuits with novel pharmaceutical drugs would be helpful additions to lifestyle interventions for the treatment of obesity. The recent FDA approval of two anti-obesity drugs holds promise in a field in which previous drugs were removed from clinical use because of unacceptable psychiatric and cardiovascular side effects. Here, the modes of action of anti-obesity drugs are reviewed. © 2012 Elsevier Ltd. Source

We report transplantation outcomes of 258 children with Hurler syndrome (HS) after a myeloablative conditioning regimen from 1995 to 2007. Median age at transplant was 16.7 months and median follow-up was 57 months. The cumulative incidence of neutrophil recovery at day 60 was 91%, acute graft-versus-host disease (GVHD) (grade II-IV) at day 100 was 25%, and chronic GVHD and 5 years was 16%. Overall survival and event-free survival (EFS) at 5 years were 74% and 63%, respectively. EFS after HLA-matched sibling donor (MSD) and 6/6 matched unrelated cord blood (CB) donor were similar at 81%, 66% after 10/10 HLA-matched unrelated donor (UD), and 68% after 5/6 matched CB donor. EFS was lower after transplantation in 4/6 matched unrelated CB (UCB) (57%; P = .031) and HLA-mismatched UD (41%; P = .007). Full-donor chimerism (P = .039) and normal enzyme levels (P = .007) were higher after CB transplantation (92% and 98%, respectively) compared with the other grafts sources (69% and 59%, respectively). In conclusion, results of allogeneic transplantation for HS are encouraging, with similar EFS rates after MSD, 6/6 matched UCB, 5/6 UCB, and 10/10 matched UD. The use of mismatched UD and 4/6 matched UCB was associated with lower EFS. Source

Discover hidden collaborations